Cancer Diagnosis by Treatment Group
75 Questions
0 Views

Cancer Diagnosis by Treatment Group

Created by
@IndustriousPun

Podcast Beta

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is a potential drawback of using frozen section in breast cancer diagnosis?

  • Difficulty in assessing fatty breast tissue
  • Adds significant time to the procedure (correct)
  • Insufficient sensitivity for DCIS
  • Compromises cosmetic outcomes

    • What is the primary benefit of using the Margin Probe system in breast cancer surgery?

  • Enhances palpation of invasive cancer
  • Improves cosmetic outcomes
  • Increases sensitivity for IDC
  • Reduces the need for re-excision surgery (correct)

    • What is a potential consequence of using full cavity shave in breast cancer surgery?

  • Compromises cosmetic outcomes (correct)
  • Improves palpation of invasive cancer
  • Reduces the need for re-excision surgery
  • Increases sensitivity for DCIS

    • What is a limitation of using full cavity shave in breast cancer surgery?

    <p>Thinner shaves can result in reduced success in clearing final margins</p> Signup and view all the answers

    What is the primary goal of using intraoperative imaging in breast cancer surgery?

    <p>To identify positive margins in real-time</p> Signup and view all the answers

    What is a necessary condition for a patient to be enrolled in the pivotal study?

    <p>The patient is at least 18 years old</p> Signup and view all the answers

    What is the purpose of suture marking the center of each of the 6 margins of the main lumpectomy specimen?

    <p>To facilitate palpation and re-excision</p> Signup and view all the answers

    What is the primary purpose of the MarginProbe device in the SOC+Device arm?

    <p>To sample 5-8 points on each face of the excised specimen</p> Signup and view all the answers

    What would disqualify a patient from enrolling in the pivotal study?

    <p>Bilateral disease in both breasts</p> Signup and view all the answers

    What is NOT a step in the resection process of the main lumpectomy specimen?

    <p>The patient is taken to the recovery room</p> Signup and view all the answers

    What is the primary effectiveness endpoint in the study?

    <p>Measurement of all pathologically positive margins on the main specimen being intraoperatively re-excised or “addressed”</p> Signup and view all the answers

    What is the definition of a positive margin in the study?

    <p>A margin microscopically measured and reported in the histology report to have cancer within 1 mm or less of the inked margin</p> Signup and view all the answers

    What is the role of intraoperative imaging in the study?

    <p>To assist in the intraoperative re-excision of positive margins</p> Signup and view all the answers

    How many patients were excluded from the study due to protocol violations or not meeting the inclusion/exclusion criteria?

    <p>7</p> Signup and view all the answers

    What is the total number of patients analyzed in the study?

    <p>293</p> Signup and view all the answers

    How many patients were analyzed in the 'device' arm of the NPL subgroup?

    <p>82</p> Signup and view all the answers

    What was the reason for excluding one patient from the study?

    <p>All of the above</p> Signup and view all the answers

    How many patients were analyzed in the 'control' arm of the study?

    <p>150</p> Signup and view all the answers

    What percentage of patients with long-term 'excellent' or 'good' cosmetic evaluation was similar in both arms?

    <p>76%</p> Signup and view all the answers

    How many margins were re-excised by the surgeons in the entire cohort and NPL subgroup, respectively?

    <p>78% (186/237) of these margins were intraoperatively re-excised</p> Signup and view all the answers

    What percentage of margins in the entire cohort were not re-excised?

    <p>57%</p> Signup and view all the answers

    Why did the surgeons not re-excise the remaining 43% of device-detected positive margins?

    <p>Because they were in the anterior or deep aspect where no breast tissue remained to be resected</p> Signup and view all the answers

    What would have been the consequence of re-excising the remaining 43% of device-detected positive margins?

    <p>The correct ISR for the 'device' arm would have increased to 67%</p> Signup and view all the answers

    What percentage of patients in the 'device' arm were able to intraoperatively re-excise all histologically positive margins?

    <p>Nearly 70%</p> Signup and view all the answers

    What is the approximate percentage of patients taken back to the operating room for additional surgery when the device was used?

    <p>Less than 20%</p> Signup and view all the answers

    What percentage of correct intraoperative reactions and reoperation rates were maintained in the control arm?

    <p>40% and 20%</p> Signup and view all the answers

    What is the increase in percentage of patients who were able to intraoperatively re-excise all histologically positive margins when using the device?

    <p>More than 75%</p> Signup and view all the answers

    What is the approximate percentage of patients in the 'device' arm who underwent preoperative image-guided localization?

    <p>Nearly 70% is not mentioned</p> Signup and view all the answers

    What percentage of American women with early-stage breast cancer are treated with BCS?

    <p>75 %</p> Signup and view all the answers

    What is the goal of a lumpectomy procedure in breast cancer treatment?

    <p>Removing the tumor with a margin of surrounding normal breast tissue</p> Signup and view all the answers

    Why is it challenging to accomplish a successful lumpectomy?

    <p>Because the microscopic extent of breast cancer can be difficult to discern</p> Signup and view all the answers

    What is a consequence of involved or positive lumpectomy margins?

    <p>Increased risk of ipsilateral breast tumor recurrence</p> Signup and view all the answers

    What is a common occurrence for patients undergoing lumpectomy?

    <p>At least 20 % of patients undergo more than one procedure</p> Signup and view all the answers

    What was the re-excision rate in the control group in the study by Allweis et al.?

    <p>12.7%</p> Signup and view all the answers

    What was the relative reduction in re-excision rates with the use of MarginProbe?

    <p>56%</p> Signup and view all the answers

    How many patients were enrolled in the study by Thill et al.?

    <p>109</p> Signup and view all the answers

    What was the re-excision rate in the MarginProbe group in the study by Coble et al.?

    <p>10.4%</p> Signup and view all the answers

    What was the study design of the study by Schnabel et al.?

    <p>Prospective, randomized, controlled</p> Signup and view all the answers

    What was the reduction in re-excision rates in the study by Hermann et al.?

    <p>44-17% = 61%</p> Signup and view all the answers

    What was the cosmesis outcome in the study by Geha et al.?

    <p>Favorable</p> Signup and view all the answers

    What was the re-excision rate in the control group in the study by Kupstas et al.?

    <p>18.3%</p> Signup and view all the answers

    What was the relative reduction in re-excision rates with the use of MarginProbe in the study by Cen et al.?

    <p>75%</p> Signup and view all the answers

    What was the study design of the study by Arch et al.?

    <p>Retrospective, single arm</p> Signup and view all the answers

    What is the estimated percentage of cases where reoperation for positive margins after BCS may be necessary?

    <p>50%</p> Signup and view all the answers

    What is the consequence of having tumor cells directly at the margin of the excised specimen?

    <p>Reoperation is required</p> Signup and view all the answers

    What is the recommended course of action for patients not amenable to margin-free lumpectomy?

    <p>Mastectomy</p> Signup and view all the answers

    What percentage of American women with early-stage breast cancer are treated with breast-conserving surgery (BCS)?

    <p>75%</p> Signup and view all the answers

    What is the estimated percentage of main lumpectomy specimens that will have positive or close margins?

    <p>54%</p> Signup and view all the answers

    What is the primary goal of a lumpectomy procedure in breast cancer treatment?

    <p>Removal of the tumor with a margin of surrounding normal breast tissue</p> Signup and view all the answers

    What is the purpose of evaluating margin status during lumpectomy?

    <p>To determine the need for further surgery</p> Signup and view all the answers

    Why is it challenging to accomplish a successful lumpectomy?

    <p>The microscopic extent of the cancer is difficult to discern</p> Signup and view all the answers

    What is the consequence of having involved or positive lumpectomy margins?

    <p>Patient discomfort, increased costs, and poorer cosmetic outcome</p> Signup and view all the answers

    What is the primary goal of breast-conserving surgery (BCS) for breast cancer?

    <p>To obtain clear margins during the operation</p> Signup and view all the answers

    What is a consequence of involved or positive lumpectomy margins?

    <p>Increased risk of ipsilateral breast tumor recurrence</p> Signup and view all the answers

    What is the goal of achieving negative margins during lumpectomy?

    <p>To reduce the need for further surgery</p> Signup and view all the answers

    What is a leading risk factor for local recurrence in breast cancer?

    <p>Failure to obtain clear margins</p> Signup and view all the answers

    What is the role of pathology data in the evaluation of lumpectomy margin status?

    <p>To provide detailed information on margin status</p> Signup and view all the answers

    What is a common occurrence for patients undergoing lumpectomy?

    <p>They undergo multiple procedures to achieve acceptable margins</p> Signup and view all the answers

    What is excluded from the study?

    <p>All of the above</p> Signup and view all the answers

    What was the outcome of using the MarginProbe device in the study?

    <p>A 56% decrease in repeat operations</p> Signup and view all the answers

    What is done to the main lumpectomy specimen?

    <p>It is oriented to delineate the six surfaces of the tissue</p> Signup and view all the answers

    What was the significance of the MarginProbe device in breast cancer surgery?

    <p>It was used to detect tumor cells at the margin of the lumpectomy specimen</p> Signup and view all the answers

    What is the consequence of involved or positive lumpectomy margins?

    <p>Increased risk of local recurrence</p> Signup and view all the answers

    What is obtained from all patients in the study?

    <p>Informed consent</p> Signup and view all the answers

    What percentage of patients in the 'device' arm were able to intraoperatively re-excise all histologically positive margins?

    <p>94.4%</p> Signup and view all the answers

    What was the outcome of the study in terms of cosmetic outcome?

    <p>There was no difference in cosmetic outcome between the two arms</p> Signup and view all the answers

    What is a common occurrence for patients undergoing lumpectomy?

    <p>Microscopic involvement of the margins</p> Signup and view all the answers

    What is the primary objective of re-excision in breast-conserving surgery for cancer?

    <p>To optimize local disease control</p> Signup and view all the answers

    What is the typical practice of surgeons and pathologists when dividing a lumpectomy specimen?

    <p>Divide the specimen into 6 aspects</p> Signup and view all the answers

    What is the consequence of involved or positive lumpectomy margins in breast cancer treatment?

    <p>Increased chances of cancer recurrence</p> Signup and view all the answers

    What is the goal of a lumpectomy procedure in breast cancer treatment?

    <p>To remove the tumor and a small amount of surrounding tissue</p> Signup and view all the answers

    Why is it challenging to accomplish a successful lumpectomy?

    <p>Because of the difficulty in obtaining clear margins</p> Signup and view all the answers

    What is the significance of re-excision in breast cancer surgery?

    <p>It optimizes local disease control</p> Signup and view all the answers

    What is the common occurrence for patients undergoing lumpectomy?

    <p>Need for re-excision</p> Signup and view all the answers

    What percentage of American women with early-stage breast cancer are treated with breast-conserving surgery?

    <p>60%</p> Signup and view all the answers

    Study Notes

    Patient Diagnosis by Treatment Group

    • 24 (8.1%) patients in the device group had invasive ductal carcinoma, 22 (7.4%) in the control group, and 7 (10.3%) in the roll-in phase.
    • 26 (8.7%) patients in the device group had invasive lobular carcinoma, 13 (4.4%) in the control group, and 2 (2.9%) in the roll-in phase.
    • 83 (27.9%) patients in the device group had ductal carcinoma in situ, 78 (26.2%) in the control group, and 19 (27.9%) in the roll-in phase.
    • 155 (52.0%) patients in the device group had mixed diagnoses, 179 (60.1%) in the control group, and 39 (57.4%) in the roll-in phase.

    Tumor Stage Results

    • The majority of patients were diagnosed with stage II breast cancer and below.

    Margin Probe

    • The Margin Probe is a device that identifies, in real-time, positive margins by detecting microscopic residual cancer and DCIS at the surface of excised breast tissue.
    • The device enables immediate action by the surgeon, thereby reducing the need for re-excision surgery.

    Limitations of Current Margin Assessment Methods

    • Gross assessment and specimen X-ray cannot palpate/visualize microscopic invasive cancer nor DCIS.
    • Frozen section analysis is difficult due to the fatty nature of breast tissue and may add significant time to the procedure.
    • Full cavity shave can compromise cosmetic outcomes due to the volume of healthy tissue removed.

    Patient Study Inclusion and Exclusion Criteria

    • Inclusion criteria: women histologically diagnosed with carcinoma of the breast, non-palpable malignant lesions, undergoing lumpectomy, and aged 18 years or more.
    • Exclusion criteria: multicentric disease, bilateral disease, neoadjuvant systemic therapy, previous radiation, prior surgical procedure, implants, pregnancy, and lactation.

    Patient Treatment

    • Patients were first enrolled and taken to the operating room for resection of the main lumpectomy specimen.
    • The main lumpectomy specimen and lumpectomy cavity palpation and related re-excisions were performed before patient randomization.
    • Patients were then randomized to either the standard of care (SOC) or SOC+Device arm intraoperatively.

    Study Endpoints

    • The primary effectiveness endpoint is measured as all pathologically positive margins on the main specimen being intraoperatively re-excised or “addressed”.
    • A positive margin is defined as a margin microscopically measured and reported in the histology report to have cancer within 1 mm or less of the inked margin.

    Background

    • Breast cancer is a common disease, and breast-conserving surgery (BCS) is a treatment option.
    • BCS involves removing the tumor and a margin of surrounding normal breast tissue.
    • Complete removal of the malignancy is crucial, but challenging due to the microscopic extent of breast cancer.

    Study Details

    • The study was a randomized, double-arm trial to evaluate the benefit of a novel device (MarginProbe) in intraoperative margin assessment for BCS.
    • 300 patients were enrolled, with 293 patients analyzed (143 in the "device" arm and 150 in the "control" arm).
    • The device was applied to the lumpectomy specimen, and additional tissue was excised according to device readings.

    Results

    • The device group had a higher rate of correct surgical reaction confirmed by histology compared to the control group.
    • In the device group, 76% of patients had "excellent" or "good" cosmetic evaluation, similar to the control group.
    • The device improved intraoperative re-excision of positive margins, with a 75% increase compared to the control arm.
    • In the NPL subgroup, device use reduced reoperation rates by over 50%.

    Non-Palpable Lesions (NPL) Subgroup

    • 168 patients were analyzed in the NPL subgroup (82 in the device arm and 86 in the control arm).
    • The device improved correct intraoperative reaction and reduced reoperation rates in the NPL subgroup.

    Conclusion

    • The study demonstrates the benefit of the MarginProbe device in intraoperative margin assessment for BCS, particularly in the NPL subgroup.
    • The device improves the detection and re-excision of positive margins, reducing reoperation rates and improving cosmetic outcomes.

    MarginProbe Peer-reviewed Literature

    • Significant and consistent reduction in positive margins and re-excision rates across multiple studies:
      • 23% reduction in re-excision rates
      • 56% reduction in positive margins
    • Studies published in various journals, including Am J Surg, Ann Surg, SpringerPlus, and Breast J
    • Study designs: Prospective, randomized, controlled, multicenter, and retrospective
    • Patient populations: 293 to 596 patients
    • Re-excision rates:
      • Control group: 12.7% to 39%
      • MarginProbe group: 5.6% to 18.3%
    • Reduction in re-excision rates: 56% to 88%
    • Cosmesis: favorable in most studies

    Positive Margins and Re-excision Rates

    • Positive margins: significant risk factor for local recurrence
    • Re-excision rates: up to 50% of cases
    • National Comprehensive Cancer Network guidelines: positive lumpectomy margins require reoperation
    • Standard practice: unacceptable to have tumor cells directly at the margin of the excised specimen

    MarginProbe Device

    • Intraoperative probe for positive margin detection in breast-conserving surgery
    • Associated with improved correct surgical reaction and decreased re-excision rates
    • Safe and effective in reducing the rate of repeat operations

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Margin Probe® Radiofrequency Spectroscopy System PDF
    MP Clinical Data PDF

    Description

    This quiz analyzes patient diagnosis by treatment group, including roll-in, device, control, and all phases. It focuses on invasive ductal carcinoma and other types of cancer.

    More Like This

    Use Quizgecko on...
    Browser
    Open
    Browser
    Browser